Skip to main content
Equibles

Ameritas Investment Partners, Inc.

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1055980 LINCOLN, NE
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$21,908
+$17,113 QoQ
Shares Held
16,724
+56.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 130 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ameritas Investment Partners, Inc. holds $63,306,181 across 267 Biotechnology names. LCTX ranks #204 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 12,422 $6,170,379
2 EXEL
Exelixis, Inc.
 75,969 $4,133,473
3 HALO
Halozyme Therapeutics, Inc.
 40,729 $3,187,858
4 CYTK
Cytokinetics Inc
 36,992 $3,151,348
5 ROIV
Roivant Sciences Ltd.
 83,064 $2,939,634
6 REGN
Regeneron Pharmaceuticals, Inc.
 4,593 $2,863,919
7 JAZZ
Jazz Pharmaceuticals plc
 11,547 $2,782,480
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 25,923 $2,112,983

All Filings in LCTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,908 16,724
2025-03-31 $4,795 10,656
2024-12-31 $5,328 10,656
2024-09-30 $9,696 10,656
2024-06-30 $10,656 10,656
2024-03-31 $15,770 10,656
2023-12-31 $11,615 10,656
2023-09-30 $12,574 10,656
2023-06-30 $15,024 10,656
2022-03-31 $14,642 9,508
2021-12-31 $23,294 9,508
2021-09-30 $23,960 9,508
2021-06-30 $27,097 9,508
2020-03-31 $4,984 6,005